Physician profile
David Rosen
NPI 1992729370
$790.59
in general payments reported to CMS, 2019-2025
7 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.17 · 2020: $15.96 · 2021: $23.94 · 2022: $65.46 · 2023: $269 · 2024: $145 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $455.28 | 2019-2024 | Scopis Ent |
| Regeneron Pharmaceuticals, INC. | $140.01 | 2025 | Dupixent |
| Intersect Ent, INC. | $75.00 | 2019 | |
| Neurent Medical Limited | $43.25 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Glaxosmithkline, LLC. | $43.19 | 2021-2022 | |
| Acclarent, INC | $17.31 | 2023 | Relieva Spinplus, Trudi Nav Cable |
| Phadia US INC. | $16.55 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.